Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sixty HIV participants will be enrolled and stratified by PBMC HIV DNA levels, either high (greater than or equal to 5000 copies/106 cells) or low (less than 5000 copies/106 cells). Individuals will be enrolled into each group until filled. Screening PBMC HIV DNA levels will be performed at SEARCH in real-time with less than one-week turn around time. All individuals will intend to initiate ARV due to meeting MOPH guidelines for such. The protocol team will work with the primary care physician to facilitate initiation of standard ARV care; however, initiation of ARV is not a requirement of the study and ARV will not be provided by the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia

NCT00777426

HIV Infections

COMPLETED

Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population

NCT00796146

Acute HIV Infection

RECRUITING

Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS

NCT02470351

Acute HIV Infection HIV CNS Involvement

COMPLETED

Functional Imaging Reserve in NeuroHIV

NCT03596268

HIV

COMPLETED

Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection

NCT00789009

HIV

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 HIV DNA will be stratified by high

No interventions assigned to this group

2 HIV DNA will be stratified by low

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* HIV-infected individuals meeting MOPH criteria to initiate HAART and planning to initiate HAART within a month of screening.
* Consequently, all participants will have plasma CD4 counts at less than 250 cells.

Exclusion Criteria

* Head injury with loss of consciousness greater than 1 hour or cognitive sequela
* Current/past illicit drug use or positive drug screen for methamphetamines, amphetamines, or cocaine at screening or entry.
* Any of the following laboratory abnormalities:

* PT/PTT \> the upper limit of normal (ULN) or INR \> 1.1
* Hemoglobin \< 9.0 mg/dL
* ALT \> 5x ULN
* serum creatinine \> 2x ULN or creatinine clearance \< 30 cc per min by Cockroft-Gault formula
* Acute illness within 30 days prior, persistent and active AIDS-defining OI of any organ system or autoimmune disease.
* Current or recent fevers or meningeal signs suggestive of CNS opportunistic infection
* CNS opportunistic infection, past or present (Patients diagnosed with opportunistic infection after CSF examination will be excluded from further analysis. In such a situation, an additional patient will be enrolled)
* History of pre-existing neurologic disease to include stroke, multiple sclerosis or psychiatric illness including schizophrenia, bipolar disorder, anxiety disorder, panic attacks, major depression, or post traumatic stress disorder. Patients with past depression that is controlled and patients with or minor depressive symptoms will be allowed to enroll.
* Known learning disability including dyslexia or unable to read or write basic Thai
* Positive Hepatitis C serology (Hepatitis C Ab)
* Confusion or other signs and symptoms of metabolic encephalopathy or delirium
* Other conditions that could explain neurocognitive decline in the opinion of the investigator such as hypothyroidism, vitamin B12 deficiency or neurosyphilis
* Pregnancy or metal objects that would preclude MRI

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes